The UK Government has confirmed up to £21.7bn in funding over 25 years for carbon capture, utilisation and storage (CCUS) and hydrogen projects.
BASF has set out a new corporate direction - including dividing its businesses into ‘core’ and ‘standalone’ units. The company’s CEO Markus Kamieth said: ‘We are convinced that BASF is at a turning point.’
So-called ‘forever chemicals’, perfluoroalkyl and polyfluoroalkyl chemicals, have been implicated in a range of health issues. The most recent studies have suggested potential issues for pregnant women and also a role in the development of colorectal cancer.
Researchers have managed to create blood stem cells in the lab that closely resemble those found in the human body. The new method would allow them to produce personalised stem cells from a patient, potentially transforming treatments for blood disorders and bone marrow transplants.